These studies also showed that NSE levels were an independent prognostic factor in the non-germinal center B-cell subtype of DLBCL, indicating that NSE may not only be a prognostic marker for disease progression but that it may also be involved in tumorigenesis. The gene discussed is ENO2; the disease is diffuse large B-cell lymphoma.